Home / Sensory organs / Erythromycin
ATC S01AA17 · Antibiotics
Erythromycin shortage
As of 2 Nov 2026, Erythromycin has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 4 products from 3 companies.
Countries2/15
Products4packs or presentations
Companies31 listed
Short since29 Sep 20179.1 years ago
Earliest return14 Dec 2026company estimate
Main reasonIncreased demand
United StatesNo reported shortageCanada3 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan1 product shortAustraliaNo reported shortage
Timeline
CanadaJapan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sawai 4887 · Tokyo
Compared with similar medicines
ATC group S01AA · AntibioticsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ODAN-ERYTHROMYCIN (50 x 1g) | ODAN LABORATORIES LTD | 29 Sep 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ODAN-ERYTHROMYCIN (3.5 g) | ODAN LABORATORIES LTD | 8 Jun 2018 | not given | Increased demand Demand increase for the drug |
| CA | ERYTHROMYCIN OPHTHALMIC OINTMENT USP (50 x 1g) | STERI-MED PHARMA INC. | 1 Oct 2026 | 14 Dec 2026 | Increased demand Demand increase for the drug |
| JP | エリスロマイシン錠200mg「サワイ」 limited | 沢井製薬 | 22 Jan 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.